We are live on ! Find out more
ALT icon

Altimmune
ALT

112 hedge funds and large institutions have $79.2M invested in Altimmune in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 40 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $898K

6% less funds holding

Funds holding: 119 → 112 (-7)

14.02% less ownership

Funds ownership: 71.55% → 57.53% (-14%)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

33% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 40

36% less capital invested

Capital invested by funds: $125M → $79.2M (-$45.3M)

Holders
112
Holders Change
-7
Holders Change %
-5.88%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
27
Reduced
40
Closed
22
Calls
$2.13M
Puts
$898K
Net Calls
+$1.24M
Net Calls Change
+$197K

Top Buyers

Rank Fund Capital Flow
1
Prudential Financial
Prudential Financial
New Jersey
+$956K
2
GCP
GSA Capital Partners
United Kingdom
+$774K
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$712K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$650K
5
XT
XTX Topco
Cayman Islands
+$588K

Top Sellers

Rank Fund Capital Flow
1
LCM
Laurion Capital Management
New York
-$2.95M
2
Millennium Management
Millennium Management
New York
-$2.42M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$2.1M
4
SFM
Sphera Funds Management
Israel
-$1.76M
5
Morgan Stanley
Morgan Stanley
New York
-$1.71M

ALT Hedge Fund Activity: Q3 2023 in Review

112 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q3 2023, worth a combined $79.2M — down 36% from $125M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ALT and 16 opened new positions — a net loss of 6 holders — while 40 trimmed existing stakes and 27 added.

The largest buyer was Prudential Financial, opening a new position worth an estimated $956K. The largest seller was Laurion Capital Management, cutting an estimated $2.95M.

  • 112 institutional investors held Altimmune (ALT) as of Q3 2023, down from 119 in Q2 2023.
  • Funds reported $79.2M of Altimmune stock for Q3 2023, down 36% quarter-over-quarter.
  • 16 funds opened new Altimmune positions in Q3 2023 and 22 closed out, a net change of -6 holders.
  • The largest Altimmune buyer in Q3 2023 was Prudential Financial, an estimated $956K added.
  • The largest Altimmune seller in Q3 2023 was Laurion Capital Management, an estimated $2.95M sold.

Based on aggregated 13F filings for Q3 2023.